{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:54:18Z","timestamp":1784242458979,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00228-022-03296-0","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T04:35:50Z","timestamp":1645504550000},"page":"1039-1045","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Reappraising the role of class Ic antiarrhythmics in atrial fibrillation"],"prefix":"10.1007","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4531-9712","authenticated-orcid":false,"given":"Dimitris","family":"Tsiachris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Doundoulakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Tsioufis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Pagkalidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos-Konstantinos","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanos M.","family":"Zafeiropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos A.","family":"Gatzoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Tsioufis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christodoulos","family":"Stefanadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,22]]},"reference":[{"issue":"23","key":"3296_CR1","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1161\/circulationaha.114.008201","volume":"129","author":"NJ Patel","year":"2014","unstructured":"Patel NJ, Deshmukh A, Pant S, Singh V, Patel N, Arora S, Shah N, Chothani A, Savani GT, Mehta K, Parikh V, Rathod A, Badheka AO, Lafferty J, Kowalski M, Mehta JL, Mitrani RD, Viles-Gonzalez JF, Paydak H (2014) Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning. Circulation 129(23):2371\u20132379. https:\/\/doi.org\/10.1161\/circulationaha.114.008201","journal-title":"Circulation"},{"key":"3296_CR2","doi-asserted-by":"publisher","unstructured":"Rozen G, Hosseini SM, Kaadan MI, Biton Y, Heist EK, Vangel M, Mansour MC, Ruskin JN (2018) Emergency department visits for atrial fibrillation in the United States: trends in admission rates and economic burden from 2007 to 2014. J Am Heart Assoc 7(15). https:\/\/doi.org\/10.1161\/jaha.118.009024","DOI":"10.1161\/jaha.118.009024"},{"issue":"1","key":"3296_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5811\/westjem.2012.1.6893","volume":"14","author":"A Sacchetti","year":"2013","unstructured":"Sacchetti A, Williams J, Levi S, Akula D (2013) Impact of emergency department management of atrial fibrillation on hospital charges. West J Emerg Med 14(1):55\u201357. https:\/\/doi.org\/10.5811\/westjem.2012.1.6893","journal-title":"West J Emerg Med"},{"issue":"9","key":"3296_CR4","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1111\/acem.13703","volume":"26","author":"A Mart\u00edn","year":"2019","unstructured":"Mart\u00edn A, Coll-Vinent B, Suero C, Fern\u00e1ndez-Sim\u00f3n A, S\u00e1nchez J, Varona M, Cancio M, S\u00e1nchez S, Carbajosa J, Malag\u00f3n F, Montull E, Del Arco C (2019) Benefits of rhythm control and rate control in recent-onset atrial fibrillation: the HERMES-AF study. Acad Emerg Med Off J Soc Acad Emerg Med 26(9):1034\u20131043. https:\/\/doi.org\/10.1111\/acem.13703","journal-title":"Acad Emerg Med Off J Soc Acad Emerg Med"},{"issue":"38","key":"3296_CR5","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37(38):2893\u20132962. https:\/\/doi.org\/10.1093\/eurheartj\/ehw210","journal-title":"Eur Heart J"},{"key":"3296_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa612","author":"G Hindricks","year":"2020","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, Boriani G, Castella M, Dan G-A, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau J-P, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL, Group ESD (2020) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart J"},{"issue":"1","key":"3296_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"CT January","year":"2019","unstructured":"January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr, Ellinor PT, Ezekowitz MD, Field ME, Furie KL, Heidenreich PA, Murray KT, Shea JB, Tracy CM, Yancy CW (2019) 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 74(1):104\u2013132. https:\/\/doi.org\/10.1016\/j.jacc.2019.01.011","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"3296_CR8","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/s0735-1097(00)01116-5","volume":"37","author":"IA Khan","year":"2001","unstructured":"Khan IA (2001) Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation. J Am Coll Cardiol 37(2):542\u2013547. https:\/\/doi.org\/10.1016\/s0735-1097(00)01116-5","journal-title":"J Am Coll Cardiol"},{"issue":"2\u20133","key":"3296_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/s0167-5273(02)00467-9","volume":"87","author":"IA Khan","year":"2003","unstructured":"Khan IA (2003) Oral loading single dose flecainide for pharmacological cardioversion of recent-onset atrial fibrillation. Int J Cardiol 87(2\u20133):121\u2013128. https:\/\/doi.org\/10.1016\/s0167-5273(02)00467-9","journal-title":"Int J Cardiol"},{"issue":"2\u20133","key":"3296_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/s0167-5273(02)00477-1","volume":"89","author":"IA Khan","year":"2003","unstructured":"Khan IA, Mehta NJ, Gowda RM (2003) Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation. Int J Cardiol 89(2\u20133):239\u2013248. https:\/\/doi.org\/10.1016\/s0167-5273(02)00477-1","journal-title":"Int J Cardiol"},{"issue":"15","key":"3296_CR11","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.ehj.2004.04.030","volume":"25","author":"J Reisinger","year":"2004","unstructured":"Reisinger J, Gatterer E, Lang W, Vanicek T, Eisserer G, Bachleitner T, Niemeth C, Aicher F, Grander W, Heinze G, K\u00fchn P, Siostrzonek P (2004) Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset. Eur Heart J 25(15):1318\u20131324. https:\/\/doi.org\/10.1016\/j.ehj.2004.04.030","journal-title":"Eur Heart J"},{"issue":"2","key":"3296_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/s0735-1097(02)02705-5","volume":"41","author":"P Chevalier","year":"2003","unstructured":"Chevalier P, Durand-Dubief A, Burri H, Cucherat M, Kirkorian G, Touboul P (2003) Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis. J Am Coll Cardiol 41(2):255\u2013262. https:\/\/doi.org\/10.1016\/s0735-1097(02)02705-5","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"3296_CR13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10557-020-07127-1","volume":"35","author":"D Tsiachris","year":"2021","unstructured":"Tsiachris D, Doundoulakis I, Pagkalidou E, Kordalis A, Deftereos S, Gatzoulis KA, Tsioufis K, Stefanadis C (2021) Pharmacologic cardioversion in patients with paroxysmal atrial fibrillation: a network meta-analysis. Cardiovasc Drugs Ther 35(2):293\u2013308. https:\/\/doi.org\/10.1007\/s10557-020-07127-1","journal-title":"Cardiovasc Drugs Ther"},{"issue":"10","key":"3296_CR14","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1093\/oxfordjournals.eurheartj.a015146","volume":"18","author":"J Azpitarte","year":"1997","unstructured":"Azpitarte J, Alvarez M, Ba\u00fan O, Garc\u00eda R, Moreno E, Mart\u00edn F, Tercedor L, Fern\u00e1ndez R (1997) Value of single oral loading dose of propafenone in converting recent-onset atrial fibrillation. Results of a randomized, double-blind, controlled study. Eur Heart J 18(10):1649\u20131654. https:\/\/doi.org\/10.1093\/oxfordjournals.eurheartj.a015146","journal-title":"Eur Heart J"},{"issue":"7","key":"3296_CR15","doi-asserted-by":"publisher","first-page":"600","DOI":"10.5152\/akd.2011.162","volume":"11","author":"I Balla","year":"2011","unstructured":"Balla I, Petrela E, Kondili A (2011) Pharmacological conversion of recent atrial fibrillation: a randomized, placebo-controlled study of three antiarrhythmic drugs. Anadolu Kardiyol Derg 11(7):600\u2013606. https:\/\/doi.org\/10.5152\/akd.2011.162","journal-title":"Anadolu Kardiyol Derg"},{"issue":"11","key":"3296_CR16","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/clc.4960181108","volume":"18","author":"F Bellandi","year":"1995","unstructured":"Bellandi F, Cantini F, Pedone T, Palchetti R, Bamoshmoosh M, Dabizzi RP (1995) Effectiveness of intravenous propafenone for conversion of recent-onset atrial fibrillation: a placebo-controlled study. Clin Cardiol 18(11):631\u2013634. https:\/\/doi.org\/10.1002\/clc.4960181108","journal-title":"Clin Cardiol"},{"issue":"5","key":"3296_CR17","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/s0002-9149(98)00412-3","volume":"82","author":"L Bianconi","year":"1998","unstructured":"Bianconi L, Mennuni M (1998) Comparison between propafenone and digoxin administered intravenously to patients with acute atrial fibrillation. PAFIT-3 Investigators. The Propafenone in Atrial Fibrillation Italian Trial. Am J Cardiol 82(5):584\u2013588. https:\/\/doi.org\/10.1016\/s0002-9149(98)00412-3","journal-title":"Am J Cardiol"},{"issue":"11 Pt 2","key":"3296_CR18","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1111\/j.1540-8159.1998.tb01203.x","volume":"21","author":"G Boriani","year":"1998","unstructured":"Boriani G, Biffi M, Capucci A, Botto G, Broffoni T, Ongari M, Trisolino G, Rubino I, Sanguinetti M, Branzi A, Magnani B (1998) Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols. Pacing Clin Electrophysiol 21(11 Pt 2):2470\u20132474. https:\/\/doi.org\/10.1111\/j.1540-8159.1998.tb01203.x","journal-title":"Pacing Clin Electrophysiol"},{"issue":"5","key":"3296_CR19","doi-asserted-by":"publisher","first-page":"50A","DOI":"10.1016\/0002-9149(92)91078-i","volume":"70","author":"KD Donovan","year":"1992","unstructured":"Donovan KD, Dobb GJ, Coombs LJ, Lee KY, Weekes JN, Murdock CJ, Clarke GM (1992) Efficacy of flecainide for the reversion of acute onset atrial fibrillation. Am J Cardiol 70(5):50A-55A. https:\/\/doi.org\/10.1016\/0002-9149(92)91078-i","journal-title":"Am J Cardiol"},{"issue":"1","key":"3296_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/s0167-5273(96)02841-0","volume":"58","author":"GL Botto","year":"1997","unstructured":"Botto GL, Capucci A, Bonini W, Boriani G, Broffoni T, Barone P, Espureo M, Lombardi R, Molteni S, Ferrari G (1997) Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimens. Int J Cardiol 58(1):55\u201361. https:\/\/doi.org\/10.1016\/s0167-5273(96)02841-0","journal-title":"Int J Cardiol"},{"issue":"5","key":"3296_CR21","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/clc.4960190515","volume":"19","author":"C Fresco","year":"1996","unstructured":"Fresco C, Proclemer A, Pavan A, Buia G, Vicentini A, Pavan D, Morgera T (1996) Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind, multicenter clinical trial. Paroxysmal Atrial Fibrillation Italian Trial (PAFIT)-2 Investigators. Clin Cardiol 19(5):409\u2013412. https:\/\/doi.org\/10.1002\/clc.4960190515","journal-title":"Clin Cardiol"},{"issue":"3","key":"3296_CR22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/s0736-4679(98)00003-1","volume":"16","author":"G Ganau","year":"1998","unstructured":"Ganau G, Lenzi T (1998) Intravenous propafenone for converting recent onset atrial fibrillation in emergency departments: a randomized placebo-controlled multicenter trial. FAPS Investigators Study Group. J Emerg Med 16(3):383\u2013387. https:\/\/doi.org\/10.1016\/s0736-4679(98)00003-1","journal-title":"J Emerg Med"},{"issue":"12","key":"3296_CR23","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/j.amjcard.2007.01.059","volume":"99","author":"GE Kochiadakis","year":"2007","unstructured":"Kochiadakis GE, Igoumenidis NE, Hamilos ME, Marketou ME, Chlouverakis GI, Vardas PE (2007) A comparative study of the efficacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recent-onset atrial fibrillation. Am J Cardiol 99(12):1721\u20131725. https:\/\/doi.org\/10.1016\/j.amjcard.2007.01.059","journal-title":"Am J Cardiol"},{"issue":"17","key":"3296_CR24","first-page":"510","volume":"102","author":"A Kondili","year":"1990","unstructured":"Kondili A, Kastrati A, Popa Y (1990) Comparative evaluation of verapamil, flecainide and propafenone for the acute conversion of atrial fibrillation to sinus rhythm. Wien Klin Wochenschr 102(17):510\u2013513","journal-title":"Wien Klin Wochenschr"},{"issue":"6","key":"3296_CR25","first-page":"521","volume":"16","author":"DA Kosior","year":"2009","unstructured":"Kosior DA, Kochanowski J, Scis\u0142o P, Piatkowski R, Postu\u0142a M, Rabczenko D, Opolski G (2009) Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: a randomized, prospective study. Cardiol J 16(6):521\u2013527","journal-title":"Cardiol J"},{"issue":"7","key":"3296_CR26","first-page":"475","volume":"1","author":"S Madonia","year":"2000","unstructured":"Madonia S, De Simone M, Brai G, Gozzo D, Gristina A, Luciano L, Maisano S, Migliore G, Mineo R, Muzzo MP, Nicchi F, Randazzo A, Raspanti G, Rotolo G, Russo A, Sagona F, Schirosa M, Spinello M, Stancampiano R, Geraci E (2000) Intravenous versus oral initial load of propafenone for conversion of recent-onset atrial fibrillation in the emergency room: a randomized trial. Ital Heart J 1(7):475\u2013479","journal-title":"Ital Heart J"},{"issue":"1","key":"3296_CR27","first-page":"41","volume":"2","author":"S Romano","year":"2001","unstructured":"Romano S, Fattore L, Toscano G, Corsini F, Coppo A, Catanzaro M, Romano A, Martone A, Caccavale F, Iodice E, Di Maggio O, Corsini G (2001) Effectiveness and side effects of the treatment with propafenone and flecainide for recent-onset atrial fibrillation. Ital Heart J Suppl 2(1):41\u201345","journal-title":"Ital Heart J Suppl"},{"issue":"1","key":"3296_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/heart.84.1.37","volume":"84","author":"NJ Alp","year":"2000","unstructured":"Alp NJ, Bell JA, Shahi M (2000) Randomised double blind trial of oral versus intravenous flecainide for the cardioversion of acute atrial fibrillation. Heart 84(1):37\u201340. https:\/\/doi.org\/10.1136\/heart.84.1.37","journal-title":"Heart"},{"issue":"10","key":"3296_CR29","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/s0002-9149(99)80655-9","volume":"75","author":"KD Donovan","year":"1995","unstructured":"Donovan KD, Power BM, Hockings BE, Dobb GJ, Lee KY (1995) Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation. Am J Cardiol 75(10):693\u2013697. https:\/\/doi.org\/10.1016\/s0002-9149(99)80655-9","journal-title":"Am J Cardiol"},{"issue":"8","key":"3296_CR30","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/eurheartj\/14.8.1127","volume":"14","author":"AH Madrid","year":"1993","unstructured":"Madrid AH, Moro C, Mar\u00edn-Huerta E, Mestre JL, Novo L, Costa A (1993) Comparison of flecainide and procainamide in cardioversion of atrial fibrillation. Eur Heart J 14(8):1127\u20131131. https:\/\/doi.org\/10.1093\/eurheartj\/14.8.1127","journal-title":"Eur Heart J"},{"issue":"9","key":"3296_CR31","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/s0002-9149(00)01128-0","volume":"86","author":"FJ Mart\u00ednez-Marcos","year":"2000","unstructured":"Mart\u00ednez-Marcos FJ, Garc\u00eda-Garmendia JL, Ortega-Carpio A, Fern\u00e1ndez-G\u00f3mez JM, Santos JM, Camacho C (2000) Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm. Am J Cardiol 86(9):950\u2013953. https:\/\/doi.org\/10.1016\/s0002-9149(00)01128-0","journal-title":"Am J Cardiol"},{"issue":"11","key":"3296_CR32","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0011-393X(05)80319-4","volume":"55","author":"M Negrini","year":"1994","unstructured":"Negrini M, Gibelli G, de Ponti C (1994) A comparison of propafenone and amiodarone in reversion of recent-onset atrial fibrillation to sinus rhythm. Curr Ther Res 55(11):1345\u20131354. https:\/\/doi.org\/10.1016\/S0011-393X(05)80319-4","journal-title":"Curr Ther Res"},{"key":"3296_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euab014","author":"OA Ibrahim","year":"2021","unstructured":"Ibrahim OA, Belley-C\u00f4t\u00e9 EP, Um KJ, Baranchuk A, Benz AP, Dalmia S, Wang CN, Alhazzani W, Conen D, Devereaux PJ, Whitlock RP, Healey JS, McIntyre WF (2021) Single-dose oral anti-arrhythmic drugs for cardioversion of recent-onset atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials. Europace. https:\/\/doi.org\/10.1093\/europace\/euab014","journal-title":"Europace"},{"issue":"12","key":"3296_CR34","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1056\/nejm199103213241201","volume":"324","author":"DS Echt","year":"1991","unstructured":"Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL et al (1991) Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 324(12):781\u2013788. https:\/\/doi.org\/10.1056\/nejm199103213241201","journal-title":"N Engl J Med"},{"issue":"6","key":"3296_CR35","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1161\/01.cir.90.6.2843","volume":"90","author":"JL Anderson","year":"1994","unstructured":"Anderson JL, Platia EV, Hallstrom A, Henthorn RW, Buckingham TA, Carlson MD, Carson PE (1994) Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST). Circulation 90(6):2843\u20132852. https:\/\/doi.org\/10.1161\/01.cir.90.6.2843","journal-title":"Circulation"},{"issue":"12","key":"3296_CR36","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/s0002-9149(02)02867-9","volume":"90","author":"T Meinertz","year":"2002","unstructured":"Meinertz T, Lip GY, Lombardi F, Sadowski ZP, Kalsch B, Camez A, Hewkin A, Eberle S (2002) Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol\/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study). Am J Cardiol 90(12):1300\u20131306. https:\/\/doi.org\/10.1016\/s0002-9149(02)02867-9","journal-title":"Am J Cardiol"},{"issue":"2","key":"3296_CR37","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.hrthm.2017.12.018","volume":"15","author":"MC Hyman","year":"2018","unstructured":"Hyman MC, Mustin D, Supple G, Schaller RD, Santangeli P, Arkles J, Lin D, Muser D, Dixit S, Nazarian S, Epstein AE, Callans DJ, Marchlinski FE, Frankel DS (2018) Class IC antiarrhythmic drugs for suspected premature ventricular contraction-induced cardiomyopathy. Heart Rhythm 15(2):159\u2013163. https:\/\/doi.org\/10.1016\/j.hrthm.2017.12.018","journal-title":"Heart Rhythm"},{"issue":"5","key":"3296_CR38","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/europace\/eux373","volume":"20","author":"GA Dan","year":"2018","unstructured":"Dan GA, Martinez-Rubio A, Agewall S, Boriani G, Borggrefe M, Gaita F, van Gelder I, Gorenek B, Kaski JC, Kjeldsen K, Lip GYH, Merkely B, Okumura K, Piccini JP, Potpara T, Poulsen BK, Saba M, Savelieva I, Tamargo JL, Wolpert C (2018) Europace 20(5):731\u2013732. https:\/\/doi.org\/10.1093\/europace\/eux373","journal-title":"Europace"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-022-03296-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-022-03296-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-022-03296-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T08:04:39Z","timestamp":1652515479000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-022-03296-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,22]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["3296"],"URL":"https:\/\/doi.org\/10.1007\/s00228-022-03296-0","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,22]]},"assertion":[{"value":"14 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}